Navigation Links
Bio-Phase II 2.0mm Suture Anchor

ProductsBio-Phase II 2.0mm Suture Anchor
Company Arthrotek (A Biomet Company)
Item Bio-Phase II 2.0mm Suture Anchor
Features 
  • Suture easily slides through the anchor
  • Material resorbs in 915 months
  • Strength retention throughout soft-tissue healing
  • Anchor pull-out strength greater than 1-0 suture breakage
  • Description LactoSorb copolymer is an absorbable co-polymer synthesized from all-natural ingredients: 82% L-Lactic acid and 18% glycolic acid. Unlike the homopolymers in common use such as 100% poly-L-lactic acid (PLLA) or 100% poly-glycolic acid (PGA), LactoSorb copolymer is substantially amorphous (without crystallinity), meaning that its degradation is uniform, precluding the crystalline release associated with degrading homopolymers that have been implicated in late inflammatory reactions. Furthermore, this co-polymer ratio permits the polymer to retain most of its strength for six to eight weeks, which is appropriate for healing, but not so long as to raise concerns about long-term stress shielding of bone. Mass loss, which always follows strength loss for absorbable polymers, occurs in a clinically relevant twelve months (approximately) for LactoSorb copolymer.
    Info Arthrotek (A Biomet Company)
    Customer Service: (800) 348-9500
    Web site: http://www.arthrotek.com

    Related medicine products :

    1. Bio-Phase II 3.0mm Suture Anchor
    2. 2.0mm Trephine with Handle
    3. Retinal Lagua Pick: 2.0mm Vertical Notch
    4. Infusion Cannula 2.0mm
    5. Light Guide Cables - 2.0mm
    6. Serdarevic Suture Hook
    7. Castroviejo Suture Forceps
    8. OGawa Straight Suture-Fixation Forceps - 0.12 mm
    9. Colibri Suture Removal Forceps
    10. Paton Extra Delicate Suture Forceps
    11. Suture tying forceps
    ... The USS Sports Medicine POLYSORB Meniscal Stapler ... the two resorbable legs of the staple. ... of tissue, specifically the meniscus. The staple ... polyester derivative of lactic acid and glycolic ...
    ... Simplicity with Clinical Lab Accuracy ... used as an accurate screen ... breath tests. In clinical trials, ... the Q.E.D.® demonstrated high correlation ...
    ... The SureStep Drug Screen Tests are ... assay for MDMA (Ecstasy). Designed using Microgenics ... is the only point of care immunoassay ... affinity for both MDA and MDEA but ...
    ... Contact Lens Comfort Drops improve comfort on contact ... contact lenses from your disinfecting system or from ... your finger and place one or two drops ... it in your eyethe lens will go in ...
    Medicine Products:
    (Date:5/28/2016)... ... May 28, 2016 , ... May 26, 2016- In ... Arts Fighting Challenge with theme event of “K Warriors” on June 4, 2016 at ... , The event is sponsored and hosted by Shaolin Institute and sanctioned by ...
    (Date:5/27/2016)... , ... May 27, 2016 , ... Two director-level employees ... YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen ... For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) ...
    (Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... ... casual readers, this installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven ... tech within the industry, from leading advocates, associations and industry leaders such as ...
    (Date:5/27/2016)... ... May 27, 2016 , ... ... students studying complementary medicine. Allison Outerbridge is this year’s Life University ... May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge is approaching ...
    (Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, ... respirators, according to court documents and SEC filings. A jury has returned ... v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury ...
    Breaking Medicine News(10 mins):
    (Date:5/27/2016)... 27, 2016 Kitov ... focused on late-stage drug development, today announced the ... of pivotal batches required for registration of KIT-302 ... This follows Kitov,s announcement in December ... met its primary efficacy endpoint. "We ...
    (Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
    (Date:5/25/2016)... HILDEN , Deutschland und GERMANTOWN, ... Zusammenarbeit mit Therawis bedient ... Entscheidungen bei Brustkrebs   QIAGEN N.V. ... QIA) gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung ... prädiktiver Assays für die Onkologie eingegangen zu sein. ...
    Breaking Medicine Technology: